4//SEC Filing
Cole Douglas G. 4
Accession 0001415889-23-008492
CIK 0001821323other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:20 PM ET
Size
5.3 KB
Accession
0001415889-23-008492
Insider Transaction Report
Form 4
Cole Douglas G.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-19+8,888→ 8,888 totalExercise: $0.64Exp: 2033-05-18→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on May 19, 2024
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001486373
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:20 PM ET
- Size
- 5.3 KB